NCT05951153View on ClinicalTrials.gov

Tributyrin to Promote Gut Health Among Children Undergoing Hematopoietic Cell Transplantation

EARLY_PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 1, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2026

Conditions
Hematopoietic Cell Transplantation (HCT)
Interventions
COMBINATION_PRODUCT

Tributyrin

Tributyrin is a nutritional supplement prepared by esterification of glycerin with butyric acid that promotes delivery of free butyrate to distal portions of the gut.

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER

NCT05951153 - Tributyrin to Promote Gut Health Among Children Undergoing Hematopoietic Cell Transplantation | Biotech Hunter | Biotech Hunter